MiMedx Group, Inc. (MDXG) income statement
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3036% below fair value
$3.11−0.07 (-2.20%)
Close on Nov 19, 2026Market cap $453.83MP/E –Yield –
MiMedx Group, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 77.3%
- Operating margin
- -8.3%
- Net margin
- -6.3%
- Return on equity, FY2025
- 21.6%
Financial strength
- Current ratio
- 4.35
- Debt to equity
- 0.00
- Debt to assets
- 0.0%
- Cash to current liabilities
- 280.7%
Valuation
- P/E ratio
- –
- Price to sales
- 1.49
- Price to book
- 2.15
- Dividend yield
- –
See a number that looks wrong?